AMN Healthcare Services, Inc. (AMN)
NYSE: AMN · Real-Time Price · USD
47.42
-0.32 (-0.67%)
At close: Nov 5, 2026, 4:00 PM EST
47.50
+0.08 (0.17%)
After-hours: Nov 5, 2026, 7:30 PM EST

AMN Healthcare Services Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
109.02-95.7-146.98210.68444.05327.39
Depreciation & Amortization
137.75156.6173.78160.93137.11103.7
Other Amortization
1.161.16---0.16
Loss (Gain) From Sale of Assets
-20.84-20.840.078.051.562.71
Asset Writedown & Restructuring Costs
109.52109.52222.46---
Loss (Gain) From Sale of Investments
-0.11-0.110.20.30.75-0.05
Stock-Based Compensation
32.9732.9722.0918.4929.5425.24
Provision & Write-off of Bad Debts
2.482.483.323.91586.26
Other Operating Activities
-112.41-17.65-40.4-0.06-16.72-16.55
Change in Accounts Receivable
71.5771.57223.45221.0628.91-585.27
Change in Accounts Payable
-20.57-20.57-154.89-183.5248.78256.12
Change in Unearned Revenue
6.026.02-1.34-0.56-4.14.32
Change in Income Taxes
3.183.18-4.013.79-8.886.59
Change in Other Net Operating Assets
40.8440.8422.7-90.91-65.28174.74
Operating Cash Flow
360.57269.46320.42372.17653.73305.36
Operating Cash Flow Growth
35.20%-15.90%-13.90%-43.07%114.09%18.90%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-35.63-35.63-80.89-103.69-75.83-53.57
Cash Acquisitions
----292.18-69.57-41.26
Divestitures
65.2865.28----
Sale (Purchase) of Intangibles
----1.7-5.09-0.09
Investment in Securities
-25.37-25.377.729.971.3-3.48
Other Investing Activities
-50.90.02-6.76-24.9-21.52-8.99
Investing Cash Flow
-46.624.3-79.94-412.49-170.71-107.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-530125815-70
Long-Term Debt Repaid
--815-375-355.3--91.88
Net Debt Issued (Repaid)
-285-285-250459.7--21.88
Repurchase of Common Stock
-2.09-2.09-8.48-437.89-591.87-9.92
Other Financing Activities
165.62-8.8-0.97-11.08--3.1
Financing Cash Flow
-121.47-295.89-259.4510.73-591.87-34.9

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
------0.34
Net Cash Flow
192.48-22.13-18.97-29.6-108.84162.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
324.94233.83239.53268.48577.9251.78
Free Cash Flow Growth
45.84%-2.38%-10.78%-53.54%129.52%14.90%
Free Cash Flow Margin
9.24%8.56%8.03%7.08%11.02%6.32%
Free Cash Flow Per Share
8.226.076.276.8212.885.24
Levered Free Cash Flow
339.54249.93263.32276.29494.47244.01
Unlevered Free Cash Flow
359.22277.27307.01310.13519.72265.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
45.1145.1161.0348.137.5238.09
Cash Income Tax Paid
7.857.8528.1578.26213.81106.38
Change in Working Capital
101.03101.0385.91-50.13-0.56-143.49
SEC Filings: 10-K · 10-Q